ESC 365 - Management of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with non-valvular atrial fibrillation (NVAF) who are older and frail, with moderate renal impairment and multiple comorbidities.

Open Access

Management of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with non-valvular atrial fibrillation (NVAF) who are older and frail, with moderate renal impairment and multiple comorbidities.

Session: Management of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with non-valvular atrial fibrillation (NVAF) who are older and frail, with moderate renal impairment and multiple comorbidities

Topic: Atrial Fibrillation (AF)

Speaker: Associate Professor R. Collins (Dublin, IE) Doctor J. Cosin Sales (Valencia, ES)

Sponsored by Bristol Myers Squibb and Pfizer

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speakers

Associate Professor Ronan Collins

Tallaght University Hospital, Dublin (Ireland)

7 presentations

2 followers

Doctor Juan Cosin Sales

HOSPITAL ARNAU DE VILANOVA, Valencia (Spain)

3 presentations

1 follower

Access the full session

Management of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with non-valvular atrial fibrillation (NVAF) who are older and frail, with moderate renal impairment and multiple comorbidities

Speakers: Associate Professor R. Collins, Doctor J. Cosin Sales

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by